Data Vantage | AUM Biosciences, SCG Cell Therapy, Blood and Hello Health disclose updates
Edition #263, 6 Apr 2023
Dear Reader,
AUM Biosciences, a Singapore-headquartered biotech company focused on precision oncology therapeutics, allotted shares worth $11.8 million earlier this week.
Everlife Holdings, a market access and distribution company in India and Southeast Asia, received the bulk of the new shares. AUM Biosciences had announced a $27 million Series A round led by Everlife in 2021.
Last October, the biotech company disclosed its plans to go public via a merger with Mountain Crest Acquisition Corp. V, a Nasdaq-listed special purpose acquisition company (SPAC). The deadline for the business combination has been extended to May 16, 2023, according to a recent filing by the SPAC.
Top shareholders in AUM Biosciences
Source: DATA VANTAGE
SCG Cell Therapy, a clinical-stage biotech company, received $8.2 million last week from Smartech Investment Holdings and other investors. The firm’s share price is up 26% from its previous round in 2021.
SCG Cell Therapy is currently valued at $210 million.
Executives at top investors, financial services firms and businesses use DATA VANTAGE to make smarter investment decisions in Asia. See how.
Other updates from DATA VANTAGE
Singapore-headquartered consumer products company Blood, which makes period care products such as sanitary pads, menstrual cups and cramp relief patches, received S$2.1 million ($1.58 million) this week from DSG Consumer Partners and other investors. The funding is understood to be part of a new Series A round.
Hello Health, a health and wellness content platform, allocated shares worth $1.05 million to Australia-based Brenteca Investments this week. The Singapore-headquartered firm, which claims to have over 34 million unique monthly users, has previously been reported to be eyeing a listing on the Australian stock exchange (ASX).
Pre-clinical biotech firm Phoska Biopharma received $1.2 million from SPRIM Ventures, Albrekca LLC and other investors last week. This is a new funding round for the company, which had earlier bagged $1 million in 2022.
Study aboard platform Leap is buying back some shares from its co-founder Arnav Kumar for $1.15 million, per regulatory filings. The company had raised $75 million in a Series D round led by Owl Ventures last year.
Deep tech company EyRIS allotted shares worth $1.07 million to parent novaHEALTH Pte, a subsidiary of Malaysia-listed Nova MSC, and others last week. The startup has developed a deep learning system (DLS) solution capable of performing automated image analyses to detect eye diseases.
Indian edtech unicorn Eruditus posted an 87% revenue growth in the fiscal year ended June 30, 2022, while its net losses expanded to $386.81 million.
EQT-backed private healthcare provider HMI Group reported a 58% revenue growth for the year ended June 30, 2022. Its net profit went up by over 216% during the period.
Insurtech firm PolicyPal reported an over 126% surge in its net loss for the financial year ended Dec 31, 2021. Its revenue increased by 13% during the period.
DealStreetAsia — Professional
Combine editorial insights with robust data & research. Subscribing to DealStreetAsia — Professional will get you -
- Key financials, fundraising data and shareholding information for over 2,500 Asian venture-backed companies registered in Singapore and Indonesia
- Up to 4 new research reports per month
- Monthly and quarterly data on private funding in SE Asia, India and Greater China
- Full access to DealStreetAsia’s premium stories and archives
- Twice-weekly DATA VANTAGE newsletter
- Discounts on tickets to our flagship events
Our webinar will address significant issues that have cast a shadow over BYJU’S and raised doubts about the sustainability of the edtech sector, especially now that its pandemic-induced surge is fizzling.
Tune in to hear what could be one of the most essential discussions on Indian edtech this year.
Sign Up Now © DEALSTREETASIA 2014–2023.
